Supportive approaches for Alzheimer disease.
Publication
, Journal Article
Davis, NJ; Hendrix, CC; Superville, JG
Published in: The Nurse practitioner
August 2011
Alzheimer disease (AD) accounts for most dementia diagnoses. Acetylcholinesterase inhibitors and antipsychotics are first-line drug therapies for cognitive decline and to manage neuropsychiatric symptoms, respectively. Because AD is relentlessly progressive, NPs will need to provide long-term support to patients and their caregivers.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
The Nurse practitioner
DOI
EISSN
1538-8662
ISSN
0361-1817
Publication Date
August 2011
Volume
36
Issue
8
Start / End Page
22 / 29
Related Subject Headings
- Time Factors
- Social Support
- Nurse-Patient Relations
- Nurse Practitioners
- Humans
- Cognition Disorders
- Cholinesterase Inhibitors
- Caregivers
- Antipsychotic Agents
- Alzheimer Disease
Citation
APA
Chicago
ICMJE
MLA
NLM
Davis, N. J., Hendrix, C. C., & Superville, J. G. (2011). Supportive approaches for Alzheimer disease. The Nurse Practitioner, 36(8), 22–29. https://doi.org/10.1097/01.npr.0000399724.54519.ae
Davis, Nicole J., Cristina C. Hendrix, and Jemma G. Superville. “Supportive approaches for Alzheimer disease.” The Nurse Practitioner 36, no. 8 (August 2011): 22–29. https://doi.org/10.1097/01.npr.0000399724.54519.ae.
Davis NJ, Hendrix CC, Superville JG. Supportive approaches for Alzheimer disease. The Nurse practitioner. 2011 Aug;36(8):22–9.
Davis, Nicole J., et al. “Supportive approaches for Alzheimer disease.” The Nurse Practitioner, vol. 36, no. 8, Aug. 2011, pp. 22–29. Epmc, doi:10.1097/01.npr.0000399724.54519.ae.
Davis NJ, Hendrix CC, Superville JG. Supportive approaches for Alzheimer disease. The Nurse practitioner. 2011 Aug;36(8):22–29.
Published In
The Nurse practitioner
DOI
EISSN
1538-8662
ISSN
0361-1817
Publication Date
August 2011
Volume
36
Issue
8
Start / End Page
22 / 29
Related Subject Headings
- Time Factors
- Social Support
- Nurse-Patient Relations
- Nurse Practitioners
- Humans
- Cognition Disorders
- Cholinesterase Inhibitors
- Caregivers
- Antipsychotic Agents
- Alzheimer Disease